CHU de Montpellier
Montpellier, 34000, France
NCT Number: NCT07204847
The objective of this multicentric observational study is to evaluate the prognostic influence of adherence or non-adherence to the recommended coronary angiography timeframe (within 24 hours) and the six-month prognosis of the patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Montpellier, 34000, France
Primary Objective: To describe the predictive values (sensitivity and specificity) of the timing of coronary angiography after the diagnosis of NSTEMI.
Secondary Objective: To evaluate an optimal threshold for the timing of coronary angiography that predicts poor prognosis at 6 months (Composite MACCE criterion including all-cause death, recurrent myocardial infarction, hospitalization for cardiac reasons, stroke) (MACCE = Major Adverse Cardiac and Cerebral Events, stroke = cerebrovascular accident).
Comparisons:
Comparison of severe events at 6 months (Composite MACCE criterion including all-cause death, recurrent myocardial infarction, hospitalization for cardiac reasons, stroke) based on the timing of coronary angiography after the diagnosis of NSTEMI according to recommendations (within 24 hours vs. more than 24 hours).
Comparison of severe events at 6 months (all-cause death, recurrent myocardial infarction, hospitalization for cardiac reasons, stroke, considered separately) based on the timing of coronary angiography after the diagnosis of NSTEMI according to recommendations (within 24 hours vs. more than 24 hours).
Comparison of severe events at 1 month (Composite MACCE criterion including all-cause death, recurrent myocardial infarction, hospitalization for cardiac reasons, stroke) based on the timing of coronary angiography after the diagnosis of NSTEMI according to recommendations (within 24 hours vs. more than 24 hours).
Comparison of the occurrence of severe events (Composite MACCE criterion including all-cause death, recurrent myocardial infarction, hospitalization for cardiac reasons, stroke, treated as survival data) based on the timing of coronary angiography after the diagnosis of NSTEMI according to recommendations (within 24 hours vs. more than 24 hours).
Additional Descriptions:
Description of the prevalence of patients for whom the recommended timing of coronary angiography is followed.
Comparison of the characteristics of patients who underwent coronary angiography within 24 hours versus those who did not (age, LVEF (left ventricular ejection fraction), troponin level, creatinine, NYHA class (New York Heart Association heart failure classification)).
Comparison of the length of hospitalization based on the timing of coronary angiography.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From enrollment to 6 months
Sensibility and specificity, positive and negative predictive values
Time frame: From enrollment to 6 months
Using a receiver operating characteristic (ROC) curve
Time frame: From enrollment to 6 months
Composite of overall mortality, recurrent myocardial infarction, stroke and hospitalization for heart failure
Time frame: From enrollment to 1 month
Composite criteria of overall mortality, recurrent myocardial infarction, stroke and hospitalization for heart failure
Time frame: From enrollment to 6 months
Overall mortality, recurrent myocardial infarction, stroke and hospitalization for heart failure
Time frame: At enrollment
Within 24 hours
Time frame: From enrollment to 6 months
Time frame: 6 months
Duration in days between the date of admission at the participating hospital and the date of discharge during the index hospitalization
University Hospital, Montpellier
Other
Prognostic Impact of Guideline-recommended Timing for Invasive Strategy in NSTEMI: a Prospective Real-world Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07343076
Cardiovascular Diseases, Heart Diseases
View Trial DetailsNCT05175261
Cardiovascular Diseases, Heart Diseases
Burlington, Vermont, United States
View Trial DetailsNCT06404515
ASCVD, Acute Coronary Syndrome
New York, United States
View Trial DetailsNCT01197742
Cardiovascular Diseases, Diabetes
München, Germany
View Trial Details